Related references
Note: Only part of the references are listed.High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma
S. Akhtar et al.
BONE MARROW TRANSPLANTATION (2010)
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging
Craig H. Moskowitz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution
J. A. Shafer et al.
LEUKEMIA & LYMPHOMA (2010)
A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425
Cindy L. Schwartz et al.
BLOOD (2009)
Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation
Alexander Claviez et al.
BLOOD (2009)
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome
Stephen P. Robinson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Phase II Study of Weekly Gemcitabine and Vinorelbine for Children With Recurrent or Refractory Hodgkin's Disease: A Children's Oncology Group Report
Peter D. Cole et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma
A. Claviez et al.
BONE MARROW TRANSPLANTATION (2008)
Managing relapsed and refractory Hodgkin lymphoma
Pauline Brice
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: An analysis from the lymphoma working party of the European group for blood and marrow transplantation
Anna Sureda et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Pediatric Hodgkin lymphoma: Maximizing efficacy and minimizing toxicity
David. C. Hodgson et al.
SEMINARS IN RADIATION ONCOLOGY (2007)
Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease
Sarah S. Donaldson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Ifosfamide, gemcitabine, and vinorelbine: a now induction regimen for refractory and relapsed Hodgkin's lymphoma
Armando Santoro et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
APE chemotherapy for children with relapsed Hodgkin disease: A pediatric oncology group trial
RS Wimmer et al.
PEDIATRIC BLOOD & CANCER (2006)
Experience with bortezomib for the treatment of patients with relapsed classical Hodgkin lymphoma
A Younes et al.
BLOOD (2006)
A pilot study of myeloablative (MA) autologous stem cell (AutoSCT) followed by reduced intensity (RI) allogeneic transplantation (AlloSCT) in children and adolescents with relapsed Hodgkin's Disease (HD) and non-Hodgkin's lymphoma (NHL)
MB Bradley et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Long-term follow-up of people who have survived cancer during childhood
Roderick Skinner et al.
LANCET ONCOLOGY (2006)
Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure
B Campbell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease -: Results of the German Hodgkin Study Group
JU Rüffer et al.
LEUKEMIA & LYMPHOMA (2005)
Salvage therapy of progressive and recurrent Hodgkin's disease:: Results from a multicenter study of the pediatric DAL/GPOH-HD study group
G Schellon et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Treatment of refractory Hodgkin's lymphoma patients with an iodine-131-labeled murine anti-CD30 monoclonal antibody
R Schnell et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation
KS Peggs et al.
LANCET (2005)
Fertility preservation for young patients with cancer: who is at risk and what can be offered?
WHB Wallace et al.
LANCET ONCOLOGY (2005)
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma:: A retrospective analysis from the German Hodgkin Lymphoma Study Group
A Josting et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)
A Josting et al.
ANNALS OF ONCOLOGY (2005)
Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease
CH Moskowitz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: Results and prognostic indices
YE Lieskovsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Outcome after autologous hemopoietic stem cell transplantation in relapsed or refractory childhood Hodgkin disease
S Stoneham et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)
A pilot study of rituximab in patients with recurrent, classic Hodgkin disease
A Younes et al.
CANCER (2003)
Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease
FE van Leeuwen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation
K Spaepen et al.
BLOOD (2003)
Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy
RS Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation
AJ Peniket et al.
BONE MARROW TRANSPLANTATION (2003)
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study
C Metayer et al.
BLOOD (2003)
Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK)
SJ Proctor et al.
ANNALS OF ONCOLOGY (2003)
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease:: a randomised trial
N Schmitz et al.
LANCET (2002)
Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation
LE Bath et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2002)
New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's Lymphoma Study Group
A Josting et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites
TP Vassilakopoulos et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2001)
Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease
A Martín et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model
CH Moskowitz et al.
BLOOD (2001)
High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: Atopy predicts idiopathic diffuse lung injury syndromes
J Frankovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Autologous stem cell transplantation for advanced Hodgkin's disease in children
A Verdeguer et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
